NASDAQ: AKTX
Akari Therapeutics PLC Stock Forecast, Predictions & Price Target

Analyst price target for AKTX

Based on 1 analyst offering 12 month price targets for Akari Therapeutics PLC

Min Forecast
$5.00+395.05%
Avg Forecast
$5.00+395.05%
Max Forecast
$5.00+395.05%

Should I buy or sell AKTX stock?

Based on 1 analyst offering ratings for Akari Therapeutics PLC.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AKTX stock forecasts and price targets.

AKTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-18

1 of 1

AKTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AKTX$1.03$5.00+385.44%Strong Buy
IRD$1.11$6.33+470.54%Strong Buy
DOMH$4.55N/AN/A
OTLK$1.96$9.00+359.18%Buy
FBRX$9.98$61.00+511.22%Strong Buy

Akari Therapeutics Stock Forecast FAQ

Is Akari Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AKTX) stock is to Strong Buy AKTX stock.

Out of 1 analyst, 1 (100%) are recommending AKTX as a Strong Buy, 0 (0%) are recommending AKTX as a Buy, 0 (0%) are recommending AKTX as a Hold, 0 (0%) are recommending AKTX as a Sell, and 0 (0%) are recommending AKTX as a Strong Sell.

If you're new to stock investing, here's how to buy Akari Therapeutics stock.

What is AKTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AKTX price target, the average AKTX price target is $5.00, with the highest AKTX stock price forecast at $5.00 and the lowest AKTX stock price forecast at $5.00.

The Wall Street analyst predicted that Akari Therapeutics's share price could reach $5.00 by Jul 18, 2026. The average Akari Therapeutics stock price prediction forecasts a potential upside of 385.44% from the current AKTX share price of $1.03.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.